Search Videos and More
UCSF Musculoskeletal Center is Redefining Pain Management and Non-surgical Treatments for Complex Conditions
At the UCSF Musculoskeletal Center, innovative research is changing how we approach musculoskeletal conditions. By going beyond traditional treatments and exploring cutting-edge technology, the center is pioneering new solutions to complex health issues affecting millions.UCSF Urology Experts Present Innovative Research and Treatment at National Urology Conference
Uncovering mechanisms of resistance to treatment in prostate cancer and improving response to cellular therapies in bladder cancer, are among the topics UCSF clinicians discussed at the American Urological Association’s 2026 Annual Meeting.Can Artificial Intelligence Reduce Invasive Testing and Improve Cardiac Diagnostics?
Coronary heart disease is the leading cause of adult death worldwide.How Personalized, Evidence-Based Care Improves High-Risk Pregnancy Outcomes
High-risk complications occur in 6% to 8% of pregnancies in the U.S. and require specialized treatment to ensure the best possible outcomes for both the pregnant patient and the fetus.Assessing First Seizures: Steps for Primary Care Providers
Neurologist Manu Hegde, MD, PhD, breaks seizures into basic classes and puts the numerous epilepsy syndromes into three useful categories. He discusses how to take better histories; what to check for during physical exams; and what to know about antiseizure drugs, including specific side effects.A Novel Approach to Aching Knees: How Specialists Are Using Artery Embolization for Osteoarthritis
Many providers have grown weary of offering the same old treatments – physical therapy, steroid injections – to their patients with knee OA, an increasingly prevalent condition that accounts for more than 80% of OA-related chronic pain and disability in the U.S.Erectile Dysfunction: Guide to Diagnosis and Complete Care for a Common Condition
This presentation from urologist John Lindsey, MD, lays out the numerous contributing factors as well as treatments for erectile dysfunction, which affects about 30 million men in U.S. but isn’t always discussed during regular checkupsMandibulectomy and Reconstruction Restores Quality of Life for Patient With Rare Disorder: UCSF Case Study
34-year-old woman with Fanconi anemia (FA) and oral dysplasia presented to the UCSF Head and Neck Surgery Cancer Program with mucosal changes involving the tongue and mandibular gingiva.New Spine Surgery Chief Shapes UCSF’s Status as Global Leader
Rajiv Sethi, MD, PhD, has been appointed chief of the UCSF Division of Orthopaedic Spine Surgery, one of the nation’s premier spine programs.Navigate the New World of Genetic Testing: Tips and Tools for PCPs
In this practical yet nuanced talk, gastroenterologist Aparajita Singh, MD, MPH, describes technological advances and dwindling barriers that are making tests for pathogenic gene variants more valuable and available than ever before.Keeping the Eye in Sight: Ensure Proper Primary Care for Ocular Injuries
When presented with common eye issues – from corneal abrasions and foreign bodies to potentially fractured orbital bones – providers need to make prompt diagnoses, assess urgency and take steps to limit damage.Benign Prostatic Hyperplasia: Tried-and-True Versus New Treatments
Justin Ahn, MD, covers evaluation essentials for patients with signs of BPH; what to know about various medical therapies, including side effects; and the bounty of today’s surgical options.Brain Stimulation That Adapts to Parkinson’s Patients’ Every Step
UC San Francisco researchers have developed a new form of deep brain stimulation (DBS) that adjusts in real time as a person walks, helping improve gait and reduce falls in people with Parkinson’s disease.Panel Issues First Guidelines to Prevent Anal Cancer in People With HIV
Results from a national study led by UC San Francisco informed the first guidelines at the federal level in the United States to detect and treat anal cancer precursor lesions in people with HIV to reduce the risk of developing anal cancer.‘Every Time I Relapsed, There Would Be a New Course of Therapy’
He was told cancer would kill him in two to four years. Fourteen years later, he credits a series of medications and treatments funded by the National Institutes of Health.Focusing on Blurry Vision: Tips and Tools for Making the Right Diagnosis
From simple refractive issues to dry eye to age-related cataracts to emergencies such as retinal detachment, the causes of painless fuzzy vision vary widely in urgency.UCSF Stroke Clinic
The stroke clinic provides expert consultations and outpatient care to patients who are at risk of a stroke or have had a stroke due to neurovascular conditions.Adult Acquired Buried Penis: Improving Patient Outcomes
Adult-acquired buried penis (AABP) is a condition in which excess or abnormal surrounding soft tissue covers the penis, resulting in sexual and urinary dysfunction. While it’s associated with obesity, AABP does not typically subside with weight loss.This New Treatment Can Adjust to Parkinson's Symptoms in Real Time
People with Parkinson’s disease have a new treatment option, thanks to U.S. Food and Drug Administration approval of groundbreaking new technology.Scientists Discover a New Hormone that Can Build Strong Bones
A newly discovered hormone that keeps the bones of breastfeeding women strong could also help bone fractures heal and treat osteoporosis in the broader population.Knee and Hip Replacements: Tips and Tools to Optimize Your Referrals
Noting the prevalence of osteoarthritis and a general lack of consistency in which patients are referred, orthopedic surgeon Claudio Diaz Ledezma, MD, lays out efficient evaluation strategies for primary care providers.The UCSF Hip Preservation Center: Where Hurting Hips Go to Become Happy Hips
See how our specialists work together and use advanced techniques to address all types of hip injuries in all types of patients, including infants and athletes.Saras Ramanathan, MD, Appointed Editor-in-Chief of Journal of Academic Ophthalmology
Saras Ramanathan, MD, has been appointed as Editor-in-Chief of the Journal of Academic Ophthalmology (JAO)UCSF Cancer Researcher Thomas Martin Receives $4.6 million CIRM Grant
UC San Francisco’s Thomas G. Martin, MD, a leading expert in blood cancers, has received a grant of nearly $4.6 million from the California Institute of Regenerative Medicine (CIRM) to produce a CAR T cell therapy for multiple myeloma, the second most common malignancy among blood cancers.